Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 2086 AL 2100

Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders

Xiao M, Xiao ZJ, Yang B, Lan Z, Fang F.

Front Neurosci. 2020 Aug 6;14:764. doi: 10.3389/fnins.2020.00764. eCollection 2020.

Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities

Kim TW, Koo SY, Studer L.

Front Cell Dev Biol. 2020 Aug 6;8:729. doi: 10.3389/fcell.2020.00729. eCollection 2020.

Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics

Kelly K, West AB.

Front Neurosci. 2020 Aug 6;14:807. doi: 10.3389/fnins.2020.00807. eCollection 2020.

Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probes

Zeng Z, Roussakis AA, Lao-Kaim NP, Piccini P.

Neurobiol Aging. 2020 Nov;95:264-270. doi: 10.1016/j.neurobiolaging.2020.07.012. Epub 2020 Jul 21.

Autonomic Dysfunction in the Synucleinopathies

Coon EA.

Semin Neurol. 2020 Oct;40(5):492-501. doi: 10.1055/s-0040-1713844. Epub 2020 Sep 9.

The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases

Goldstein DS.

Semin Neurol. 2020 Oct;40(5):502-514. doi: 10.1055/s-0040-1713874. Epub 2020 Sep 9.

Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges

Palma JA, Kaufmann H.

Semin Neurol. 2020 Oct;40(5):523-539. doi: 10.1055/s-0040-1713846. Epub 2020 Sep 9.

Animal Model for Lower Urinary Tract Dysfunction in Parkinson's Disease

Kitta T, Ouchi M, Chiba H, Higuchi M, Togo M, Abe-Takahashi Y, Kusakabe N, Shinohara N.

Int J Mol Sci. 2020 Sep 7;21(18):6520. doi: 10.3390/ijms21186520.

The movement disorder society clinical criteria for progressive supranuclear palsy:The movie version

Reich SG.

Parkinsonism Relat Disord. 2020 Sep;78:198-199. doi: 10.1016/j.parkreldis.2020.08.026. Epub 2020 Aug 25.

Diagnosis, treatment and management of apathy in Parkinson's disease: a scoping review

Mele B, Van S, Holroyd-Leduc J, Ismail Z, Pringsheim T, Goodarzi Z.

BMJ Open. 2020 Sep 9;10(9):e037632. doi: 10.1136/bmjopen-2020-037632.

CHIP as a therapeutic target for neurological diseases

Zhang S, Hu ZW, Mao CY, Shi CH, Xu YM.

Cell Death Dis. 2020 Sep 9;11(9):727. doi: 10.1038/s41419-020-02953-5.

Parkinson's Disease-Induced Zebrafish Models: Focussing on Oxidative Stress Implications and Sleep Processes

Robea MA, Balmus IM, Ciobica A, Strungaru S, Plavan G, Gorgan LD, Savuca A, Nicoara M.

Oxid Med Cell Longev. 2020 Aug 18;2020:1370837. doi: 10.1155/2020/1370837. eCollection 2020.

Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351

Oh M, Oh SJ, Lee SJ, Oh JS, Roh JH, Chung SJ, Lee JH, Lee CS, Kim JS.

Clin Nucl Med. 2020 Nov;45(11):841-847. doi: 10.1097/RLU.0000000000003261.

Peripheral insulin and amylin levels in Parkinson's disease

Sánchez-Gómez A, Alcarraz-Vizán G, Fernández M, Fernández-Santiago R, Ezquerra M, Cámara A, Serrano M, Novials A, Muñoz E, Valldeoriola F, Compta Y, Martí MJ.

Parkinsonism Relat Disord. 2020 Oct;79:91-96. doi: 10.1016/j.parkreldis.2020.08.018. Epub 2020 Aug 25.

Calcium, Bioenergetics, and Parkinson's Disease

Zampese E, Surmeier DJ.

Cells. 2020 Sep 8;9(9):2045. doi: 10.3390/cells9092045.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias